|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0144576,
umls-concept:C0205263,
umls-concept:C0205420,
umls-concept:C0282460,
umls-concept:C0332174,
umls-concept:C0332283,
umls-concept:C0441771,
umls-concept:C0443252,
umls-concept:C1274040,
umls-concept:C1522449
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-12-23
|
|
pubmed:abstractText |
Long-term results of a phase II study on the use of induction chemotherapy (CHT) using paclitaxel (P)-carboplatin (C) followed by a concurrent radiation therapy (RT) and weekly P and consolidation PC were reviewed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
79-85
|
|
pubmed:meshHeading |
pubmed-meshheading:21150466-Adenocarcinoma,
pubmed-meshheading:21150466-Adult,
pubmed-meshheading:21150466-Aged,
pubmed-meshheading:21150466-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21150466-Carboplatin,
pubmed-meshheading:21150466-Carcinoma, Large Cell,
pubmed-meshheading:21150466-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:21150466-Carcinoma, Squamous Cell,
pubmed-meshheading:21150466-Combined Modality Therapy,
pubmed-meshheading:21150466-Disease Progression,
pubmed-meshheading:21150466-Female,
pubmed-meshheading:21150466-Follow-Up Studies,
pubmed-meshheading:21150466-Humans,
pubmed-meshheading:21150466-Lung Neoplasms,
pubmed-meshheading:21150466-Male,
pubmed-meshheading:21150466-Middle Aged,
pubmed-meshheading:21150466-Paclitaxel,
pubmed-meshheading:21150466-Radiotherapy Dosage,
pubmed-meshheading:21150466-Remission Induction,
pubmed-meshheading:21150466-Survival Rate,
pubmed-meshheading:21150466-Time Factors,
pubmed-meshheading:21150466-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Long-term results of a phase II trial of induction paclitaxel-carboplatin followed by concurrent radiation therapy and weekly paclitaxel and consolidation paclitaxel-carboplatin in stage III non-small cell lung cancer.
|
|
pubmed:affiliation |
Radiation Oncology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain. fcasas@clinic.ub.es
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|
